01/15/2025
3:22 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:10 PM | Brainstorm Cell Therapeutics (Issuer)
Dagher Ibrahim B. (Reporting)
| Form 3/A | |
01/07/2025
3:11 PM | Brainstorm Cell Therapeutics (Issuer)
Dagher Ibrahim B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:30 PM | ARBEL IRIT (Reporting)
Brainstorm Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:31 PM | Bairu Menghisteab (Reporting)
Brainstorm Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:31 PM | Brainstorm Cell Therapeutics (Issuer)
HARTOUNIAN HARTOUN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:32 PM | Brainstorm Cell Therapeutics (Issuer)
Lindborg Stacy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:32 PM | Brainstorm Cell Therapeutics (Issuer)
Naor Nir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:33 PM | Brainstorm Cell Therapeutics (Issuer)
Patlis Alla (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:34 PM | Brainstorm Cell Therapeutics (Issuer)
Yablonka Uri (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:34 PM | Brainstorm Cell Therapeutics (Issuer)
Polverino Anthony J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
01/03/2025
4:36 PM | Brainstorm Cell Therapeutics (Issuer)
FRENKEL JACOB A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:36 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
2:24 PM | ARMISTICE CAPITAL, LLC (Filed by)
Brainstorm Cell Therapeutics (Subject)
| Form SC 13G | |
11/13/2024
6:55 AM | Brainstorm Cell Therapeutics (Subject)
Ruck Matthew J (Filed by)
| Form SC 13G | |
10/30/2024
7:41 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
7:00 AM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
7:00 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2024
11:15 PM | Brainstorm Cell Therapeutics (Filer)
| Form EFFECT | |
09/26/2024
3:30 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2024
3:30 PM | Brainstorm Cell Therapeutics (Filer)
| Form S-3/A | |
09/17/2024
2:32 PM | Brainstorm Cell Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/16/2024
3:36 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2024
11:15 PM | Brainstorm Cell Therapeutics (Filer)
| Form EFFECT | |
08/28/2024
4:01 PM | Brainstorm Cell Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/16/2024
6:00 AM | Brainstorm Cell Therapeutics (Filer)
| Form DEF 14A | |
08/16/2024
6:03 AM | Brainstorm Cell Therapeutics (Filer)
| Form ARS | |
08/14/2024
7:01 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
6:15 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2024
3:08 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4/A | |
07/31/2024
3:09 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4/A | |
07/31/2024
3:05 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4/A | |
07/31/2024
3:06 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4/A | |
07/31/2024
3:06 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4/A | |
07/31/2024
3:07 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4/A | |
07/31/2024
3:07 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4/A | |
07/24/2024
3:05 PM | Brainstorm Cell Therapeutics (Issuer)
Dagher Ibrahim B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:05 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2024
9:49 AM | Brainstorm Cell Therapeutics (Filer)
| Form 424B5 | |
06/28/2024
6:30 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
8:00 AM | Brainstorm Cell Therapeutics (Filer)
| Form 424B5 | |
Tesla Shares Soar After Trump Win (Act Now) (Ad) Are you ready to see why Tesla might be the biggest opportunity on the market today?
Right now, Tesla stock is at a critical juncture, and Lance believes it’s primed for explosive growth.
That’s why he’s giving away his eBook, The Bullish Case for Tesla, for FREE—but only for a limited time. ➡️ Click here to get your copy now! |
06/26/2024
3:01 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
8:03 PM | Brainstorm Cell Therapeutics (Issuer)
HARTOUNIAN HARTOUN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/25/2024
8:04 PM | Brainstorm Cell Therapeutics (Issuer)
HARTOUNIAN HARTOUN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
4:24 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
5:05 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
8:00 AM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:00 AM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
6:53 AM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
6:41 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
8:14 AM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
3:06 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
3:01 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:06 PM | Brainstorm Cell Therapeutics (Issuer)
Dagher Ibrahim B. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/19/2024
5:05 AM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
8:31 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
5:10 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
5:05 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
3:15 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
8:16 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/01/2024
7:15 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
7:54 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
7:55 PM | Brainstorm Cell Therapeutics (Issuer)
Patlis Alla (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
7:56 PM | Brainstorm Cell Therapeutics (Issuer)
Yablonka Uri (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
7:57 PM | Brainstorm Cell Therapeutics (Issuer)
Lindborg Stacy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
9:06 AM | Brainstorm Cell Therapeutics (Subject)
Ness Kevin Dean (Filed by)
| Form SC 13G/A | |
